This inventor holds 1 USPTO granted patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Overview of Inventor Thomas Wüest and His Contributions
Introduction: Thomas Wüest is an innovative inventor based in Zurich, Switzerland, known for his significant contributions to the field of biomedical research. His groundbreaking work primarily focuses on the development of antibodies specifically targeting Fibroblast Activation Protein (FAP), which plays a crucial role in various medical conditions.
Latest Patents: Thomas Wüest holds a patent for "Anti-fibroblast activation protein antibodies and methods and uses thereof." This invention provides specific binding members, particularly antibodies and their fragments, that recognize both human and mouse FAP. The anti-FAP antibodies show potential in diagnosing and treating conditions associated with activated stroma, including but not limited to wound healing, epithelial cancers, osteoarthritis, rheumatoid arthritis, cirrhosis, and pulmonary fibrosis. The antibodies exemplified by the novel antibodies ESC1 1 and ESC 14 can be used in therapy alongside chemotherapeutics, immune modulators, or other anti-cancer agents.
Career Highlights: Wüest's career is marked by his affiliation with the Ludwig Institute for Cancer Research Limited, where he has been instrumental in advancing cancer research through targeted therapies. His work reflects a commitment to improving diagnostic and therapeutic options for patients suffering from various diseases related to activated stroma.
Collaborations: During his career, Thomas Wüest has collaborated with esteemed colleagues such as Christoph Renner and Eliane Fischer. These partnerships have enriched his research endeavors and facilitated the sharing of knowledge and expertise in the field of cancer therapeutics.
Conclusion: Thomas Wüest's contributions to the science of antibody development have paved the way for potential advancements in the diagnosis and treatment of several serious health conditions. His work exemplifies the vital role inventors play in bridging the gap between scientific research and clinical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile